Your browser doesn't support javascript.
loading
Proteasome Inhibition Sensitizes Liposarcoma to MDM2 Inhibition with Nutlin-3 by Activating the ATF4/CHOP Stress Response Pathway.
Ludwig, Michael P; Galbraith, Matthew D; Eduthan, Neetha Paul; Hill, Amanda A; Clay, Michael R; Tellez, Cristiam Moreno; Wilky, Breelyn A; Elias, Anthony; Espinosa, Joaquin M; Sullivan, Kelly D.
Afiliação
  • Ludwig MP; Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Galbraith MD; Department of Pediatrics, Section of Developmental Biology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Eduthan NP; Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Hill AA; Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Clay MR; Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Tellez CM; Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Wilky BA; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Elias A; Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Espinosa JM; Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Sullivan KD; Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
Cancer Res ; 83(15): 2543-2556, 2023 08 01.
Article em En | MEDLINE | ID: mdl-37205634
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lipossarcoma / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lipossarcoma / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article